Treatment with low doses of luteolin reduces doxorubicin toxicity in MCF-7 cells by increasing Bcl-2 expression
Bjork, A

Abbreviations AC: Adenylate cyclase ATP: Denosine triphosphate BAT: Brown adipose tissue BCAAs: Branched-chain amino acids BCKA: Branched-chain keto acids BMI: Body mass index cAMP: Cyclic adenosine monophosphate CNS: Central nervous system CREB: CAMP response element-binding DIO: Diet-induced obesity DPP- 4: Dipeptidyl peptidase- 4 EGFR: Epidermal growth factor receptor EPACs: Exchange proteins directly activated by Camp Foxo1: Nuclear transcription factor GIP: Glucose-dependent insulinotropic polypeptide GIPRAb: GIP receptor antagonist antibody GPCRs: G-protein-coupled receptors GTP: Guanine triphosphate HbA1c: Glycated haemoglobin HSL: Hormone-sensitive lipase ICV: Intracerebroventricular IR: Insulin resistance LAGIPRA: Long-acting GIP receptor agonist MAPK: Mitogen activated protein kinase MASLD: Metabolically associated steatotic liver disease PI3 K-PKB/Akt: Phosphoinositide- 3-kinaseprotein kinase B/Akt PKA: Protein kinase A SUR1: Sulfonylurea receptor 1 T2DM: Type 2 diabetes mellitus TORCs: Transducers of regulated CREB protein activity ZDF: Zucker diabetic fatty References Murray CJL, Aravkin AY, Zheng P, et al

Therefore, in this review we detail the direct and indirect molecular mechanisms by which incretin receptor agonists inhibit fibrotic signalling pathways, and critically appraise the evidence for their preclinical and clinical efficacy in fibrotic disorders across diverse tissues, including the liver, heart, kidney, lung, and joints (Table 1
Ann Intern Med 166 , 637648, (2017)